Literature DB >> 28101821

Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.

Hong Truong1, Sarah E Hegarty2, Leonard G Gomella1, William K Kelly3, Edouard J Trabulsi1, Costas D Lallas1, Veda N Giri4.   

Abstract

Patients with suspected hereditary renal cell cancer (RCC) are under-referred for genetic evaluation. Characterizing the prevalence and characteristics of suspected inherited RCC is a crucial step toward advancing personalized, genetically-based cancer risk management for patients and their families. To evaluate the prevalence and characteristics of suspected inherited RCC syndromes based on consensus criteria, we performed a cross-sectional analysis of patients with a diagnosis of RCC in SEER (2001-2011, n = 105,754) and in our institutional cancer registry (2004-2013, n = 998). Consensus criteria for referral of patients with RCC for genetic evaluation from the American College of Medical Genetics and Genomics and National Society of Genetic Counselors (ACMG/NSGC) were applied to the two cohorts. The associations between meeting referral criteria with demographic characteristics were assessed with chi-square tests. Overall, 24.0 % of the SEER cohort and 33.7 % of our institutional cohort met ACMG/NSGC referral criteria for genetic counseling. While white patients more commonly met early onset clear cell RCC criteria, black patients met papillary RCC criteria at twice the rate of whites in both cohorts (p < 0.0001). As many as 1 in 5 individuals with RCC meet referral criteria for genetic evaluation based on newly emerging guidelines, with differences in pathology noted by race. Prospective genetic testing studies utilizing emerging referral guidelines should help to refine the genetic spectrum of inherited kidney cancer. This study supports efforts to increase awareness of referral of patients with RCC for genetic counseling particularly among urologic providers.

Entities:  

Keywords:  Genetic counseling; Hereditary cancer syndromes; Kidney cancer; Race

Mesh:

Year:  2017        PMID: 28101821     DOI: 10.1007/s10897-016-0020-4

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  19 in total

1.  Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).

Authors:  S Störkel; J N Eble; K Adlakha; M Amin; M L Blute; D G Bostwick; M Darson; B Delahunt; K Iczkowski
Journal:  Cancer       Date:  1997-09-01       Impact factor: 6.860

2.  Comparative Analysis of Smoking as a Risk Factor among Renal Cell Carcinoma Histological Subtypes.

Authors:  Neel H Patel; Kristopher M Attwood; Michael Hanzly; Terrance T Creighton; Diana C Mehedint; Thomas Schwaab; Eric C Kauffman
Journal:  J Urol       Date:  2015-04-18       Impact factor: 7.450

3.  Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology.

Authors:  M Kiuru; V Launonen; M Hietala; K Aittomäki; O Vierimaa; R Salovaara; J Arola; E Pukkala; P Sistonen; R Herva; L A Aaltonen
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

Authors:  L Schmidt; K Junker; N Nakaigawa; T Kinjerski; G Weirich; M Miller; I Lubensky; H P Neumann; H Brauch; J Decker; C Vocke; J A Brown; R Jenkins; S Richard; U Bergerheim; B Gerrard; M Dean; W M Linehan; B Zbar
Journal:  Oncogene       Date:  1999-04-08       Impact factor: 9.867

Review 5.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics.

Authors:  Heli J Lehtonen
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.446

8.  Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.

Authors:  Patrick R Benusiglio; Sophie Giraud; Sophie Deveaux; Arnaud Méjean; Jean-Michel Correas; Dominique Joly; Marc-Olivier Timsit; Sophie Ferlicot; Virginie Verkarre; Caroline Abadie; Dominique Chauveau; Dominique Leroux; Marie-Françoise Avril; Jean-François Cordier; Stéphane Richard
Journal:  Orphanet J Rare Dis       Date:  2014-10-29       Impact factor: 4.123

9.  A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.

Authors:  Heather Hampel; Robin L Bennett; Adam Buchanan; Rachel Pearlman; Georgia L Wiesner
Journal:  Genet Med       Date:  2014-11-13       Impact factor: 8.822

Review 10.  BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports.

Authors:  J R Toro; M-H Wei; G M Glenn; M Weinreich; O Toure; C Vocke; M Turner; P Choyke; M J Merino; P A Pinto; S M Steinberg; L S Schmidt; W M Linehan
Journal:  J Med Genet       Date:  2008-01-30       Impact factor: 6.318

View more
  3 in total

1.  Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease.

Authors:  Junlong Wu; Hongkai Wang; Christopher J Ricketts; Youfeng Yang; Maria J Merino; Hailiang Zhang; Guohai Shi; Hualei Gan; W Marston Linehan; Yao Zhu; Dingwei Ye
Journal:  Cancer       Date:  2018-12-12       Impact factor: 6.860

2.  The effect of age on cancer-specific mortality in patients with small renal masses: A population-based analysis.

Authors:  Marco Bandini; Michele Marchioni; Raisa S Pompe; Zhe Tian; Tristan Martel; Felix K Chun; Luca Cindolo; Anil Kapoor; Francesco Montorsi; Shahrokh F Shariat; Alberto Briganti; Pierre I Karakiewicz
Journal:  Can Urol Assoc J       Date:  2018-03-19       Impact factor: 1.862

Review 3.  Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review.

Authors:  Ruth T Casey; Anne Y Warren; Jose Ezequiel Martin; Benjamin G Challis; Eleanor Rattenberry; James Whitworth; Katrina A Andrews; Thomas Roberts; Graeme R Clark; Hannah West; Philip S Smith; France M Docquier; Fay Rodger; Vicki Murray; Helen L Simpson; Yvonne Wallis; Olivier Giger; Maxine Tran; Susan Tomkins; Grant D Stewart; Soo-Mi Park; Emma R Woodward; Eamonn R Maher
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.